Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt and even reverse the course of...
Company has raised $112m in order to develop therapies for central nervous system disorders - News - PharmaTimes
Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Sofinnova Partners created and seed financed Noema in 2019 to advance clinical assets in-licensed from Roche This milestone underscores Sofinnova's ability to form, build and grow companies around